Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.

The molecular mechanisms of pulmonary fibrosis are poorly understood. We have used oligonucleotide arrays to analyze the gene expression programs that underlie pulmonary fibrosis in response to bleomycin, a drug that causes lung inflammation and fibrosis, in two strains of susceptible mice (129 and C57BL/6). We then compared the gene expression patterns in these mice with 129 mice carrying a null mutation in the epithelial-restricted integrin beta6 subunit (beta6(-/-)), which develop inflammation but are protected from pulmonary fibrosis. Cluster analysis identified two distinct groups of genes involved in the inflammatory and fibrotic responses. Analysis of gene expression at multiple time points after bleomycin administration revealed sequential induction of subsets of genes that characterize each response. The availability of this comprehensive data set should accelerate the development of more effective strategies for intervention at the various stages in the development of fibrotic diseases of the lungs and other organs.

[1]  Andrius Kazlauskas,et al.  Diverse Signaling Pathways Activated by Growth Factor Receptors Induce Broadly Overlapping, Rather Than Independent, Sets of Genes , 1999, Cell.

[2]  L. Kobzik,et al.  Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. , 1999, The Journal of clinical investigation.

[3]  D. Denhardt,et al.  Osteopontin Function in Pathology: Lessons from Osteopontin-Deficient Mice , 1999, Nephron Experimental Nephrology.

[4]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[5]  C. Chresta,et al.  Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop , 1999, Oncogene.

[6]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[7]  M. Lindstrom,et al.  Heterogeneous expression of the lipocalin NGAL in primary breast cancers , 1998, International journal of cancer.

[8]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Talmadge E. King Jr.,et al.  Update in Pulmonary Medicine , 1998, Annals of Internal Medicine.

[10]  T. Hartman,et al.  Idiopathic pulmonary fibrosis: current concepts. , 1998, Mayo Clinic proceedings.

[11]  B. Hogan,et al.  Altered wound healing in mice lacking a functional osteopontin gene (spp1). , 1998, The Journal of clinical investigation.

[12]  R. Swiderski,et al.  Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. , 1998, The American journal of pathology.

[13]  L. Wodicka,et al.  Genome-wide expression monitoring in Saccharomyces cerevisiae , 1997, Nature Biotechnology.

[14]  M. Haase,et al.  Cellular distribution of c-Jun and c-Fos in rat lung before and after bleomycin induced injury , 1997, Virchows Archiv.

[15]  D. Meek,et al.  Modifications of p53 protein and accumulation of p21 and gadd45 mRNA in TGF-beta 1 growth inhibited cells. , 1997, Cellular signalling.

[16]  B. Nielsen,et al.  Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. , 1996, Gut.

[17]  D. Sheppard,et al.  A point mutation in the integrin beta 6 subunit abolishes both alpha v beta 6 binding to fibronectin and receptor localization to focal contacts. , 1995, American journal of respiratory cell and molecular biology.

[18]  R. McAnulty,et al.  Increased type I procollagen mRNA transcripts in the lungs of mice during the development of bleomycin-induced fibrosis. , 1994, The European respiratory journal.

[19]  W. Black,et al.  The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.

[20]  H. Sengeløv,et al.  Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils. , 1994, Biochemical and biophysical research communications.

[21]  R. Locksley,et al.  Constructing polycompetitor cDNAs for quantitative PCR (J. Immunol. Methods 165 (1993) 37-46). , 1994, Journal of immunological methods.

[22]  B. de Crombrugghe,et al.  Enhanced type III collagen gene expression during bleomycin induced lung fibrosis. , 1993, Thorax.

[23]  T. Ley,et al.  Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. , 1992, The Journal of biological chemistry.

[24]  C. Haslett,et al.  The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. , 1988, The American review of respiratory disease.

[25]  M. Kris,et al.  Bronchoalveolar lavage cell populations in bleomycin lung toxicity. , 1987, Thorax.

[26]  D. Hyde,et al.  Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. , 1983, The American journal of pathology.

[27]  G. Snider,et al.  Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology. , 1978, The American review of respiratory disease.

[28]  Robert V Farese,et al.  Inactivation of the Integrin [36 Subunit Gene Reveals a Role of Epithelial Integrins in Regulating Inflammation in the Lungs and Skin , 2002 .

[29]  W. Leonard,et al.  Jaks and STATs: biological implications. , 1998, Annual review of immunology.

[30]  W. El-Deiry,et al.  Regulation of p53 downstream genes. , 1998, Seminars in cancer biology.

[31]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[32]  G. Snider,et al.  Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[33]  R. D. McCoy,et al.  Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. , 1996, The Journal of clinical investigation.